Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA-Related Cancers

Clinical trial NCT02396433 · WITHDRAWN

Trial details

NCT number: NCT02396433
Sponsor: The University of Texas Health Science Center at San Antonio
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer of the Breast

Start date: 2015-04-01
Primary completion: 2015-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.